Literature DB >> 3921265

beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.

A Thabaut, A Philippon, M Meyran.   

Abstract

A total of 4093 non-replicate Pseudomonas aeruginosa isolates supplied by 10 French hospitals from September 1981 to August 1983 was examined for susceptibility to ticarcillin (TIC) and to 11 other beta-lactam antibiotics. Overall incidence of TIC-resistance was low (20.9%) but variable between hospital, unit and culture site and primarily mediated by a constitutive beta-lactamase as observed by iodometric detection (66.3%). As suggested by analytical isoelectrofocusing on gel, PSE-1 (CARB-2) and OXA types were predominant but new types appeared. The comparative in vitro activities of 12 antipseudomonal beta-lactams appreciated by microtiter MICs with an inoculum of 10(5) CFU were established according to phenotype: TIC-susceptible, TIC-R with a constitutive beta-lactamase (PSE-1, OXA-1, OXA-2, OXA-3, PSE-2 and a new type, TEM-1 and TEM-2 and derepressed cephalosporinase) or without detectable activity. Different patterns of resistance were demonstrated, but imipenem, ceftazidime and aztreonam were the most active antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921265

Source DB:  PubMed          Journal:  Chemioterapia        ISSN: 0392-906X


  3 in total

1.  Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.

Authors:  Philip E Coudron
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 2.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.